01:09 PM EDT, 07/10/2025 (MT Newswires) -- KalVista Pharmaceuticals ( KALV ) shares were down more than 2% in recent Thursday trading after the company reported its fiscal 2025 results.

Earlier, the firm posted a net loss of $3.69 per diluted share for the year, compared with a loss of $3.44 in fiscal 2024.

Analysts polled by FactSet expected a loss of $3.57.

No revenue for the fiscal year ended April 30 was reported.

KalVista said its cash, cash equivalents and marketable securities were $220.6 million on April 30, providing runway into 2027.

Price: 15.53, Change: -0.46, Percent Change: -2.88